Alvotech Initiates a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
Prolia® and Xgeva® (denosumab) are indicated for the treatment of bone disease, with combined sales…
News
Rhythm Pharmaceuticals Announces Early Access Authorization for Setmelanotide for Use in Patients with Bardet-Biedl Syndrome in France
— Reimbursed early access program allows for patients in France to receive setmelanotide for treatment…
Amarin to Report Second Quarter 2022 Financial Results and Host Conference Call on August 3, 2022
DUBLIN, Ireland and BRIDGEWATER, N.J., July 20, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN)…
Auron Therapeutics announces $48 million Series A financing to drive novel oncology pipeline leveraging a machine learning, multi-omics-based platform
Auron expands its leadership team with the appointments of David Millan, Ph.D., as Chief Scientific…
ProKidney Appoints Kerry Cooper, M.D., as Senior Vice President of Medical Affairs
Extensive Nephrology Medical Affairs Leadership and Clinical Practice Expertise Brought to ProKidney WINSTON-SALEM, NC, July…
SalioGen Therapeutics Strengthens its Leadership Team to Advance its Gene Coding™ Platform
CAMBRIDGE, Mass., July 20, 2022 (GLOBE NEWSWIRE) — SalioGen Therapeutics, a privately held biotechnology company…
Spectral Medical Provides Update on Tigris Clinical Trial
Provides positive case study on patient enrolled at University of Michigan 14 clinical sites actively…
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
FDA acknowledges that data from a randomized withdrawal period of Study C602 have the potential…
Rhythm Pharmaceuticals Announces Early Access Authorization for Setmelanotide for Use in Patients with Bardet-Biedl Syndrome in France
— Reimbursed early access program allows for patients in France to receive setmelanotide for treatment…
Aquestive Therapeutics to Report Second Quarter 2022 Financial Results and Recent Business Highlights on August 2 and Host Conference Call on August 3 at 8:00 a.m. ET
WARREN, N.J., July 20, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
Brickell Biotech Regains Compliance with Nasdaq Minimum Bid Price Requirement
BOULDER, Colo., July 20, 2022 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a…
Abeona Therapeutics Regains Compliance with Nasdaq Listing Requirements
NEW YORK and CLEVELAND, July 20, 2022 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO)…
Avicanna and Ei. Ventures Enter into an Agreement to Develop and Commercialize Adaptogen Nutraceuticals
Psilly™ Avicanna and Ei. Ventures Psilly™ branded functional fungi-based products will be developed by Avicanna…
Kraig Biocraft Laboratories Releases First Behind the Scenes Look into the Production of Recombinant Spider Silk
ANN ARBOR, Mich., July 20, 2022 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)…
TELA Bio Awarded Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc.
MALVERN, Pa., July 20, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
Societal CDMO Selected To Provide Tech Transfer And Manufacturing Services To Support Clinical Development Of An Oral Solid Dose Product In Europe
Agreement Highlights Momentum in Onshoring of Contract Manufacturing Projects to U.S. from Sites Around the…
Skye Bioscience Updates Phase 1 Timeline
San Diego, California, July 20, 2022 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”…
George Medicines advances triple combination candidate GMRx4 into Phase II clinical development for first-line treatment of type 2 diabetes
George Medicines advances triple combination candidate GMRx4 into Phase II clinical development for first-line treatment…
First Orion Expands Branded Communication To Reach Nearly Two-Thirds of U.S. Mobile Consumers
Expansion enables branded calling to reach 280M devices – accelerating the widespread adoption of secure…
Find peace of mind with Verizon Care Smart and Apple Watch
Help your loved ones live safely and independently with Get Help features, available exclusively for…